Product: Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by:  Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories
Reason for recall: GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Recall initiated: 20190509
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated